Skip to content

Eli Lilly Under Fire For Illegal Off Label Marketing of Zyprexa

February 22, 2010

Eli Lilly fraudulently marketed Zyprexa to children and elderly, according to allegations by the State of ArkansasAttorney General Dustin McDaniel says the company pushed Zyprexa to treat dementia, aggression, depression, and sleep disorders among adults when it was only approved to treat schizophrenia and bipolar disorders. The drug reportedly caused diabetes in children because of weight gain while on the drug. Eli Lilly & Co. doesn’t admit wrongdoing but will pay a record $18.5 million to settle the allegations.

To report prescription drug fraud and Medicaid Fraud, contact Frohsin & Barger.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: